中西医结合学报
中西醫結閤學報
중서의결합학보
JOURNAL OF CHINESE INTEGRATIVE MDEICINE
2012年
6期
695-700
,共6页
王菊勇%郭净%董昌盛%郑展%王青
王菊勇%郭淨%董昌盛%鄭展%王青
왕국용%곽정%동창성%정전%왕청
肺肿瘤%一氧化氮合酶%环氧化酶2%肿瘤坏死因子α%腺癌%复方%大鼠
肺腫瘤%一氧化氮閤酶%環氧化酶2%腫瘤壞死因子α%腺癌%複方%大鼠
폐종류%일양화담합매%배양화매2%종류배사인자α%선암%복방%대서
lung neoplasms%nitric oxide synthase%cyclooxygenase 2%tumor necrosis factoralpha%adenocarcinoma%compounds%rats
目的:探讨中药肺岩宁方含药血清对肿瘤坏死因子α(tumor necrosis factor-α,TNF-α)诱导的人肺癌细胞系A549诱导型一氧化氮合酶(inducible nitric oxide synthase,iNOS)和环氧合酶2(cyclooxygenase-2,COX-2)表达的影响.方法:制备肺岩宁方含药血清,以肺癌细胞系A549为靶细胞,实时聚合酶链反应法及蛋白质免疫印迹法检测肺岩宁方含药血清对TNF-α诱导的iNOS及COX-2表达的影响;二氨基乙酰乙酸荧光素检测NO产物;人iNOS重组质粒用脂质体转染法导入A549细胞24 h后,肺岩宁方含药血清治疗24 h,采用双荧光素酶报告基因系统测定肺岩宁方含药血清对TNF-α诱导的细胞核iNOS转录活性的影响.结果:与对照血清比较,TNF-α明显提高iNOS和COX-2的表达,与肺岩宁方含药血清共同作用后,显著抑制二者的表达(P<0.01,P<0.01);肺岩宁方含药血清显著降低了A549细胞经iNOS重组质粒转染后的转录活性(P<0.01,P<0.01)及NO产物的产生.结论:肺岩宁方含药血清抑制肺癌细胞的部分机制可能是抑制iNOS和COX-2基因的活性.
目的:探討中藥肺巖寧方含藥血清對腫瘤壞死因子α(tumor necrosis factor-α,TNF-α)誘導的人肺癌細胞繫A549誘導型一氧化氮閤酶(inducible nitric oxide synthase,iNOS)和環氧閤酶2(cyclooxygenase-2,COX-2)錶達的影響.方法:製備肺巖寧方含藥血清,以肺癌細胞繫A549為靶細胞,實時聚閤酶鏈反應法及蛋白質免疫印跡法檢測肺巖寧方含藥血清對TNF-α誘導的iNOS及COX-2錶達的影響;二氨基乙酰乙痠熒光素檢測NO產物;人iNOS重組質粒用脂質體轉染法導入A549細胞24 h後,肺巖寧方含藥血清治療24 h,採用雙熒光素酶報告基因繫統測定肺巖寧方含藥血清對TNF-α誘導的細胞覈iNOS轉錄活性的影響.結果:與對照血清比較,TNF-α明顯提高iNOS和COX-2的錶達,與肺巖寧方含藥血清共同作用後,顯著抑製二者的錶達(P<0.01,P<0.01);肺巖寧方含藥血清顯著降低瞭A549細胞經iNOS重組質粒轉染後的轉錄活性(P<0.01,P<0.01)及NO產物的產生.結論:肺巖寧方含藥血清抑製肺癌細胞的部分機製可能是抑製iNOS和COX-2基因的活性.
목적:탐토중약폐암저방함약혈청대종류배사인자α(tumor necrosis factor-α,TNF-α)유도적인폐암세포계A549유도형일양화담합매(inducible nitric oxide synthase,iNOS)화배양합매2(cyclooxygenase-2,COX-2)표체적영향.방법:제비폐암저방함약혈청,이폐암세포계A549위파세포,실시취합매련반응법급단백질면역인적법검측폐암저방함약혈청대TNF-α유도적iNOS급COX-2표체적영향;이안기을선을산형광소검측NO산물;인iNOS중조질립용지질체전염법도입A549세포24 h후,폐암저방함약혈청치료24 h,채용쌍형광소매보고기인계통측정폐암저방함약혈청대TNF-α유도적세포핵iNOS전록활성적영향.결과:여대조혈청비교,TNF-α명현제고iNOS화COX-2적표체,여폐암저방함약혈청공동작용후,현저억제이자적표체(P<0.01,P<0.01);폐암저방함약혈청현저강저료A549세포경iNOS중조질립전염후적전록활성(P<0.01,P<0.01)급NO산물적산생.결론:폐암저방함약혈청억제폐암세포적부분궤제가능시억제iNOS화COX-2기인적활성.
OBJECTIVE:To study the effect of Feiyanning Decoction (FYN),a compound traditional Chinese medicine,on expressions of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) activated by tumor necrosis factor-α (TNF-α) in human lung adenocarcinoma epithelial cell line (A549).METHODS:A549 cells were incubated with rat serum containing FYN for 24 h.Gene expressions of iNOS and COX-2 were determined by quantitative real-time polymerase chain reaction and Western blot.The iNOS-dependent luciferase reporter was transfected for 24 h and the cells were treated with the reagents for 24 h,then the transcriptional activity of iNOS promoter was detected by luciferase assay.The production of NO was determined by diaminofluorescein-2.RESULTS:FYN significantly inhibited TNF-α-induced expression of iNOS and COX-2 compared with the control group in A549 cells (P<0.01,P<0.01).Also,FYN inhibited the transcriptional activity of the iNOS promoter and reduced NO production compared with the control group (P<0.01,P<0.01).CONCLUSION:These results suggest that FYN inhibits iNOS and COX-2 activation induced by TNF-α,therefore,it is expected to develop a new strategy to treat lung cancer.